Preliminary studies conducted on humans and primates suggest that these issues surrounding DBS could be circumvented by ablative surgery in the STN. Patients involved in the study underwent ...
Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback